Atlas Trials

A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools

Clinical trial NCT03598621 · COMPLETED

Trial details

NCT number
NCT03598621
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2018-07-23
Primary completion
2019-01-17
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.